Treatment of community-acquired pneumonia down under versus the United States: Is it really that different?

Clinical Infectious Diseases

Volumn 46, Issue 10, 2008, Pages 1522-1524

  Mandell, Lionel ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Henderson Research Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; ERTAPENEM; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; AUSTRALIA; CANADA; CHLAMYDOPHILA; COMMUNITY ACQUIRED PNEUMONIA; COST; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE; HOSPITAL CARE; HUMAN; INTENSIVE CARE UNIT; LEGIONELLA; LENGTH OF STAY; MORTALITY; MYCOPLASMA; NOTE; PNEUMONIA SEVERITY INDEX; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UNITED STATES; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; COMPARATIVE STUDY; HOSPITALIZATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; AUSTRALIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 43249096254     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/586750     Document Type: Note

References (10)

1. Kaplan V, Clermont G, Griffin MF, et al. Pneumonia: still the old man's friend? Arch Intern Med 2003; 163:317-23.
2. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-8.
3. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006; 119:865-71.
4. Charles PGP, Whitby M, Fuller AJ, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate treatment. Clin Infect Dis 2008:46:1513-21 (in this issue).
5. Mandell L, Wunderink R, Anzeuto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia. Clin Infect Dis 2007; 44(Suppl 2):S27-72.
6. Mandell L, Marrie T, Grossman R, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31:383-421.
7. Fine M, Auble T, Yealy D, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-50.
8. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A; Toronto Invasive Bacterial Disease Network. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40:1288-97.
9. Elliott J, Anstey N, Jacups S, et al. Community-acquired pneumonia in Northern Australia: low mortality in a tropical region using locally-developed treatment guidelines. Int J Infect Dis 2005; 9:15-20.
10. Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the intensive care unit. Chest 2007; 131:779-87.